Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Point-of-Care Glucose Testing Industry Expected To Reach By 2029, Starting From 2025 Levels?
The market for point-of-care glucose testing has experienced consistent expansion over the last few years. This market is projected to expand, increasing from $4.91 billion in 2024 to reach $5.14 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 4.7%. Historically, this growth can be ascribed to several factors, including the increasing occurrence of diabetes, heightened understanding of diabetes management, the expanding elderly demographic, advancements in healthcare infrastructure, and the uptake of point-of-care testing methods.
The point-of-care glucose testing market size is expected to experience robust growth in the upcoming years. It is projected to expand to $6.5 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.0%. The anticipated growth during this period can be attributed to factors such as the expansion of telemedicine services, an increased emphasis on personalized medicine in diabetes care, a rise in diabetes management programs, augmented investment in glucose testing research and development, and the adoption of continuous glucose monitoring. Significant trends for the forecast period include the development of wearable glucose monitoring devices, the integration of smartphone connectivity in glucose testing, the expansion of point-of-care testing into home healthcare settings, the utilization of artificial intelligence for glucose data analysis, and the broadened scope of remote patient monitoring for diabetes.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp
Which Factors And Drivers Are Influencing The Point-of-Care Glucose Testing Market In 2025?
The increasing prevalence of diabetes is projected to fuel the expansion of the point-of-care glucose testing market moving forward. Diabetes, a chronic metabolic disorder, causes elevated blood glucose levels, which can progressively lead to severe damage to the heart, blood vessels, eyes, kidneys, and nerves. Point-of-care glucose testing represents a widely utilized method for assessing glucose levels in hospitalized patients, enabling swift treatment decisions in response to changes in glycemia, thereby improving therapeutic outcomes and diabetes management. For instance, in June 2024, according to The National Health Service (NHS England), a UK-based publicly funded healthcare system, the number of individuals identified by the NHS in England as having pre-diabetes reached 3,615,330 in 2023, signifying an 18% rise from 3,065,825 in 2022. Furthermore, among those under 40, cases escalated by nearly 25%, increasing from 173,166 in 2022 to 216,440 in 2023. Consequently, the rising incidence of diabetes is propelling the growth of the point-of-care glucose testing market.
What Are The Major Segments Identified In The Point-of-Care Glucose Testing Market?
The point-of-care glucose testingmarket covered in this report is segmented –
1) By Product: Lancet And Lancing Devices; Strips; Meters
2) By Testing Site: Fingertips; Alternate Site Testing
3) By Applications: Type-1 Diabetes; Type-2 Diabetes
4) By End-User: Professional Diagnostic Centers; Hospitals And Clinics; Home Care Settings; Other End Users
Subsegments:
1) By Lancet And Lancing Devices: Single-Use Lancets; Multi-Use Lancets; Adjustable Lancing Devices
2) By Strips: Glucose Test Strips; Ketone Test Strips; Combo Strips (Glucose And Ketone)
3) By Meters: Blood Glucose Meters; Continuous Glucose Monitoring (CGM) Meters; Bluetooth-Enabled Meters
How Are Emerging Market Trends Shaping The Point-of-Care Glucose Testing Industry Landscape?
Product innovation represents a primary trend gaining traction in the point-of-care glucose testing market. Major companies operating within the point-of-care glucose testing market are dedicated to developing novel products to bolster their market position. For example, in January 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company, introduced Cobas Pulse, a new point-of-care blood glucose monitor specifically for healthcare staff. This monitor will come with a companion device styled like a touchscreen smartphone, which runs its associated applications. Cobas Pulse is a handheld unit equipped with an automated glucose test strip reader, a camera, and a touchscreen, allowing for the documentation of diagnostic data. It is housed in a robust, disinfectable casing, making it suitable for use with patients of all age groups, including newborns and those in intensive care. Additionally, it seeks to optimize physicians’ workflow by running the Glucommander dosage software directly on the blood glucose reader and by facilitating the addition of downloadable decision-support apps from firms such as Smart4Diagnostics, CardioSignal, and SteadySense.
Which Key Players Are Driving Competition In The Point-of-Care Glucose Testing Market?
Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report
Which Regional Markets Are Contributing Most To The Point-of-Care Glucose Testing Industry Expansion?
North America was the largest region in the point-of-care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Point-of-Care Glucose Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12207&type=smp
Browse Through More Reports Similar to the Global Point-of-Care Glucose Testing Market 2025, By The Business Research Company
Spray Drying Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/spray-drying-equipment-global-market-report
Antidepressant Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report
Antiemetics And Antinauseants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model